✦ LIBER ✦

Rotigotine transdermal patch in combination therapy for Parkinson’s disease – observations in routine clinical practice

✍ Scribed by Ceballos-Baumann, Andres; Häck, Hermann-Josef

Book ID: 121391025
Publisher: Informa plc
Year: 2011
Tongue: English
Weight: 198 KB
Volume: 27
Category: Article
ISSN: 0300-7995
DOI: 10.1185/03007995.2011.611630

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Daytime apomorphine infusion combined wi

Daytime apomorphine infusion combined with transdermal Rotigotine patch therapy is tolerated at 2 years: A 24-h treatment option in Parkinson's disease

✍ Todorova, Antoniya; Martinez-Martin, Pablo; Martin, Anne; Rizos, Alexandra; Redd 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 170 KB

Effectiveness and tolerability of rotigo

Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany

✍ Stiasny-Kolster, Karin; Berg, Daniela; Hofmann, Werner E.; Berkels, Reinhard; Gr 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 556 KB

Parkinson's disease dementia can be easi

Parkinson's disease dementia can be easily detected in routine clinical practice

✍ Kathy Dujardin; Bruno Dubois; François Tison; Franck Durif; Isabelle Bourdeix; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract Parkinson's disease (PD) is mainly characterized by its motor manifestations, but it is also frequently associated with dementia. Early diagnosis of PD dementia (PDD) is particularly important because effective cholinesterase inhibitor treatments are available. This study aimed at valid

Combined modality therapy for early Hodg

Combined modality therapy for early Hodgkin's disease: Heterogeneity in Australasian clinical practice

✍ Roos, Daniel ;O'Brien, Peter 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

Effect of combination therapy with meman

Effect of combination therapy with memantine and rivastigmine transdermal patch on BPSD in patients with mild-to-moderate Alzheimer's disease: A 24-week prospective, multicenter, randomized, open-label clinical trial

✍ Na, Hae Ri; Choi, Seong; Yoon, Soo Jin; Park, Kyung Won; Kim, Byeong Chae; Lee, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Levodopa/DDCI and entacapone is the pref

Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort

✍ P. Damier; F. Viallet; M. Ziegler; I. Bourdeix; K. Rerat 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB